Not every possible human who has the illness will buy the drug. I think we need to be realistic with our royalties estimates. It will take years to build up a large patient base, and even then will never hit 100% saturation.
Your argument is like giving Xero a valuation of a trilllion $ because every human on earth might need to do taxes.
Ann: Neuren Corporate Presentation, October 2019, page-80
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.200(1.03%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.50 | $19.59 | $19.11 | $5.729M | 296.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259 | $19.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 640 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |